Latest News of BIIB
Results: Biogen Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Biogen Inc. reported strong Q2 earnings, surpassing revenue expectations and showing a 13% increase in EPS. Analysts predict a positive outlook for 2024, with revenue staying steady and EPS rising. De...
Is Biogen (BIIB) an Underappreciated Stock?
Patient Capital Management released its Q2 2024 investor letter for their "Patient Capital Opportunity Equity Strategy," reporting a -1.9% return compared to the S&P 500's 4.3% gain. Biogen Inc....
Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
ClearBridge Investments outperformed the Russell 1000 Value Index in Q1 2024. The ClearBridge Value Equity Strategy showed gains in most sectors, with top contributors in financial and utilities. Biog...
-
Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 3 months agoLeqembi is the first Alzheimer's treatment that alters the disease's course by removing toxic beta amyloid protein from the brain. Eisai plans to offer partial drug cost coverage in collaboration with...